The Dow initially dove about 300 points out the gate but then spent the rest of the session recovering to close almost even. The drop was triggered by new unemployment claims reaching a two-month high and thus compounding economic recovery worries that have been further exacerbated by the lack of a stimulus package to help the unemployed. As today’s expert said, “it will be difficult for unemployment to make a lot of positive headway because of the lack of stimulus.” Indexes dipped for a third straight day. The positive news is that the market is more focused now on the potential benefits that a Biden presidency would bring rather than the fear of tax hikes. But the market is much more interested in the election producing a definitive victor rather than who wins. Another positive development is that the Q3 earnings forecast has been upgraded to a 19% loss from the 25% tumble estimated on July 1st. Volume remains below average at 8.1 billion.
THU OCTOBER 15, 2020 6:32 PM
S&P 500 ends lower as investors
eye stimulus impasse
DJ: 28,514.00 -165.81 NAS: 11,768.73 -95.17 S&P: 3,488.67 -23.26 10/14
DJ: 28,494.20 -19.80 NAS: 11,713.87 -54.86 S&P: 3,483.34
-5.33 10/15
(Reuters)
- The S&P 500 ended lower on Thursday after a rise in weekly jobless claims
compounded worries about a stalling economic recovery and fading hopes for more
fiscal aid before the election. The
number of Americans filing new claims for jobless benefits rose to a two-month
high last week, stoking fears the COVID-19 pandemic was inflicting lasting
damage to the labor market. A separate
report showed manufacturing activity in New York State fell more than expected
in October.
“Going into the fall it will be difficult for unemployment to
make a lot of positive headway because of the lack of stimulus,” said
Christopher C. Grisanti, chief equity strategist, MAI Capital Management in
Cleveland. U.S. President Donald Trump
said he is willing to raise his offer of $1.8 trillion for a COVID-19 relief
deal with Democrats in Congress, but the idea was shot down by his fellow
Republican, Senate Majority Leader Mitch McConnell.
The CBOE volatility index, investors’ fear gauge, hit a one-week high and Wall
Street’s indexes dipped
for the third straight day. The S&P 500 is down about 3% from its
Sept. 2 record high close. With less
than 20 days until the Nov. 3 election, Trump and Democratic challenger Joe
Biden are set to hold dueling prime-time town halls on Thursday instead of
their second presidential debate, which was canceled after Trump declined to
take part in a virtual matchup. “More of
what moves the market will be the crystallizing of who is going to win the presidency, and how
close the Senate races are,” said Tom Martin, senior portfolio manager at
Globalt Investments in Atlanta. A Biden
presidency, coupled with a Democratic Senate, would likely mean a larger fiscal
stimulus plan than what a Republicans Senate would agree to. However, Biden is
also widely seen on Wall Street as likely to raise taxes.
Supporting the Dow Jones Industrial
Average, Walgreens Boots Alliance Inc surged 4.8% as the drugstore chain
forecast single-digit profit growth in 2021 after reporting a
better-than-expected fourth-quarter profit.
Focus is also on the quarterly results for corporate America, with
expectations for third-quarter
earnings improving to an 19% drop from a 25% tumble forecast on July 1,
according to Refinitiv IBES data.
The
Dow Jones Industrial Average fell 0.07% to end at 28,494.2 points, while the
S&P 500 lost 0.15% to 3,483.34. The
Nasdaq Composite dropped 0.47% to 11,713.87.
Morgan
Stanley MS.N rose
1.3% after it beat third-quarter
profit estimates, winding up mixed results from major U.S. lenders. Recent bank
earnings reports saw those focused on trading clocking big gains, while retail
banks took a hit from the COVID-19 pandemic.
The S&P 500
financials index climbed 0.8%, while healthcare index was the worst sector
performer, down 0.7%. The S&P 1500 airlines index .SPCOMAIR dipped
1.5% after United Airlines reported a 78% drop in quarterly revenue. Shares of Vertex Pharmaceuticals Inc
lost a fifth of their value after the drug developer discontinued its trial of
a protein deficiency disorder treatment.
Advancing issues outnumbered declining
ones on the NYSE by a 1.09-to-1 ratio; on Nasdaq, a 1.19-to-1 ratio favored
advancers. The S&P 500 posted 20 new
52-week highs and no new lows; the Nasdaq Composite recorded 59 new highs and
32 new lows.
Volume
on U.S. exchanges was 8.1 billion shares, compared with the 9.6 billion average over the last 20 trading
days.
No comments:
Post a Comment